Stability indicating LC method to determination of sodium montelukast in pharmaceutical dosage form and its photodegradation kinetics

Journal of Chromatographic Science

Volumn 49, Issue 7, 2011, Pages 540-546

  Roman, Juliana ^a   Breier, Ana R ^a   Steppe, Martin ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID DERIVATIVE; MONTELUKAST; QUINOLINE DERIVATIVE;

ARTICLE; CHEMISTRY; DRUG DOSAGE FORM; DRUG STABILITY; EVALUATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KINETICS; METHODOLOGY; PHOTOLYSIS; SENSITIVITY AND SPECIFICITY;

ACETATES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSAGE FORMS; DRUG STABILITY; KINETICS; PHOTOLYSIS; QUINOLINES; SENSITIVITY AND SPECIFICITY;

EID: 80053608569     PISSN: 00219665     EISSN: None     Source Type: Journal    
DOI: 10.1093/chrsci/49.7.540     Document Type: Article

References (25)

1. R. Ramakrishnan, E. Migoya, and B. Knorr. A population pharmacokinetic model for montelukast disposition in adults and children. Pharm. Res. 22: 532-540 (2005). (Pubitemid 40603250)
2. E.Migoya, L.Kearns,A.Hartford, J.Zhao,C.AdelsbergTozzi, B. Knorr, and P. Deutsch. Pharmacokicetics of montelukast in asthmatic patients 6 and 24months old. J.Clin. Pharmacol. 44: 487-494 (2004). (Pubitemid 38509717)
3. J. Kitchen, Q. Wang, G. Musson, Y. Yang, and L. Fisher. A semi-automated 96-well protein precipitation method for the determination of montelukast in human plasma using high performance liquid chromatography/ fluorescence detection. J Pharm Biomed Anal. 31: 647-654 (2003).
4. E. Overbeek, S. O'Sullivan, K. Leman, H. Mulder, C. Hoogsteden, and B. Prins. Effect of montelukast compared whith inhaled fluticasone on airway inflammation. J Brit Society for allergy Clin Immun. 34: 1388-1394 (2004). (Pubitemid 39233693)
5. H. Bisgaard. Pathophysiology of the cysteinyl leukotrienes and effects of leukotriene receptor antagonists in asthma. Allergy 56: 7-11 (2001). (Pubitemid 32538888)
6. A. Smith, M. Rawls, and L. Kunka. An automated method for the determination of montelukast in human plasma using dual-colunn HPLC analysis and peak height summation of the parent compound and its photodegradation product. Pharm. Res. 21: 1539-1544 (2004).
7. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH): Stability testing of new drug substance and products Q1A(R2), Switzerland, 2003.
8. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH): Validation of analytical procedures: Text and Methodology Q2(R1), Switzerland, 2005.
9. S. Spector. Safety of antileukotriene agents in asthma management. Annals of Allergy Asthma and Immunology 86:18-23 (2001). (Pubitemid 32577718)
10. S. Al-Rawithi, S. Al-Gazlan,W. Al-Ahmadi, I. Alshowaier, A. Yusuf, and D. Raines. Expedient liquid chromatography method with fluorescence detection for montelukast sodium in micro-samples of plasma. J. Chromatogr B. 8: 527-531 (2001). (Pubitemid 32261049)
11. R. Papp, P. Luk, W. Mullett, and E. Kwong. A rapid and sensitive method for the quantitation of montelukast in sheep plasma using liquid chromatography / tandem mass spectrometry. J. Chromatogr. B 858: 282-286 (2007). (Pubitemid 47513590)
12. I. Alsarra, N.Y. Khalil, M. Sultan, R. Al-Ashban, F. Belal. Spectrofluorometric determination of montelukast in dosage forms and spiked human plasma. Pharmazie. 60: 823-826 (2005). (Pubitemid 41704157)
13. H. Ochiai, N. Uchyama, T. Takamo, K. Hara, T. Kamei. Determination of montelukast sodium in human plasma by column-switching high-performance liquid chromatography with fluorescence detection. J. Chromatogr. B. 713: 409-414 (1998). (Pubitemid 29034669)
14. L.D. Liu, H.Y. Cheng, J.J. Zhao, D. Rogers. Determination of montelukast (MK-0476) and its S-enantiomer in human plasma by stereoselective high-performance liquid chromatography with column-switching. J. Pharm. Biomed. Anal. 15: 631-638 (1997). (Pubitemid 27140375)
15. T. Radhakrishna, A. Narasaraju,M. Ramakrishna, A. Satyanarayana. Simultaneous determination of montelukast and loratadine by HPLC and derivative spectrophotometric methods. J. Pharm. Biomed. Anal. 31: 359-368 (2003). (Pubitemid 36258370)
16. T.H. Hoang, R. Sharma, D. Susanto, M. Di Maso, E. Kwong. Microwave-assisted extraction of active pharmaceutical ingredient from solid dosage forms. J. Chromatogr. A 1156: 149-153 (2007). (Pubitemid 46935738)
17. I.A. Alsarra. Development of a stability-indicating HPLC method for the determination of montelukast in tablets and human plasma and its applications to pharmacokinetic and stability studies. Saudi Pharm. J. 12: 136-143 (2004). (Pubitemid 40030192)
18. I.A. Alsarra,M. Al-Omar, E. A. Gadkariem, and F. Belal. Voltametric determination of montelukast sodium in dosage forms and human plasma. Farmaco. 60: 563-567 (2005). (Pubitemid 40943395)
19. M. Al-Omari, R. Zoubi, E. Hasan, T. Knader, and A. Badwan. Effect of light and heat on the stability of montelukast in solution and its solid state. J. Pharm. Biomed. Anal. 45: 465-471 (2007). (Pubitemid 47588770)
20. Y. Shakalisava and F. Regan. Determination of montelukast sodium by capillary electrophoresis. J. Sep. Sci. 31: 1137-1143 (2008). (Pubitemid 351649841)
21. J.C. Giddings. Dynamics of Chromatography. Dekker, New York, NY, 1965, Chap. 2.
22. L.R. Snyder and J.J. Kirkland, Practical HPLC Method Development and validation, 2nd ed. Eds John Wiley & Sons, New York, USA, 1997, p. 765.
23. S. Lindsay. High Performance Liquid Chromatography, 2nd ed. Eds JohnWiley & Sons, New York, USA, 1992, p. 337.
24. United States Pharmacopoeia, 30th Rockville: United States Pharmacopoeial Convention, 2007.
25. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH): Q1B: Photostability Testing of New Drug Substances and Products Q1B, Switzerland, 1996.